| Literature DB >> 36034711 |
Berit Sletbakk Brusletto1, Bernt Christian Hellerud2, Ole Kristoffer Olstad1, Reidun Øvstebø1, Petter Brandtzaeg1,3,4.
Abstract
Background: Fulminant meningococcal sepsis with shock and multiple organ failure is associated with a massive systemic inflammatory response involving solid organs. We have previously established a porcine model of the disease to study pathophysiologic and possible therapeutic strategies. Objective: This study examined whether the organ specific gene expression profile in such a large animal model reflects the profile seen in patients with fulminant meningococcal sepsis. Patients and methods: Data from gene expression profiles induced in organs from patients (n=5) and the porcine model (n=8) were imported into the Ingenuity pathway analysis (IPA) software for comparison analysis. The number of meningococci in the organs were quantified by real time-PCR.Entities:
Keywords: IPA comparison analysis; Neisseria meningitidis; disseminated intravascular coagulation (DIC); meningococcal septic shock; organ specific transcriptional profile; porcine shock model
Mesh:
Year: 2022 PMID: 36034711 PMCID: PMC9413276 DOI: 10.3389/fcimb.2022.908204
Source DB: PubMed Journal: Front Cell Infect Microbiol ISSN: 2235-2988 Impact factor: 6.073
Experimental conditions for DNA microarray data.
| Model | Experimental conditions | Type of storage methods | Type of organ tissue | Type of array | Array description | |
|---|---|---|---|---|---|---|
| Human patients Nm septic shock model | Patients ( | Controls ( | FFPE (formalin-fixed, paraffin-embedded) | Lungs, Heart, Kidneys, Liver, and Spleen | Affymetrix GeneChip Human Transcriptome 2.0 Arrays | The array contains 44,699 protein-coding genes and 22,829 non-protein-coding genes |
| Porcine Nm septic shock experimental model | Pigs ( | Control pigs ( | FF (fresh frozen tissue) | Lungs, Kidneys, Liver, and Spleen | Affymetrix GeneChip Porcine Genome Array | The array contains 23,937 probe sets that interrogate approximately 23,256 transcripts from 20,201 |
Quantification of N.meningitidis (Nm) DNA in human and porcine tissue samples by q-PCR. In humans, Nm DNA presented as median numbers of Nm DNA copies/μg human DNA and in porcinis as median numbers of DNA copies/g tissue.
| Model | Type of organ tissue | Median numbers Nm DNA in FFPE | Type of organ tissue | Median numbers Nm DNA in FF |
|---|---|---|---|---|
|
|
| |||
|
| Lungs | 1.5x10e7 | Lungs | 2.3x10e8 |
| Heart | 2.4 x10e7 | Heart | 3.6x10e7 | |
| Kidneys | 2.0x10e6 | Kidneys | 6.3x10e7 | |
| Liver | 7.0x10e5 | Liver | 7.0x10e7 | |
| Spleen | 9.1x10e4 | Spleen | 2.5x10e7 | |
|
| ||||
|
| Lungs | 1.0x10e6/g | ||
| Kidneys | Below detection limit (1x10e4 bacteria/g tissue) | |||
| Liver | 8.0x10e5/g | |||
| Spleen | Below detection limit (1x10e4 bacteria/g tissue) |
Top upstream regulators differentially expressed (A) organs from five patients with meningococcal septic shock versus control (B) organs from eight porcinis infused exponentially with increasing numbers of N. meningitidis (reference strain H44/76) vs. controls.
| A | Human Lungs | Human Heart | Human Kidneys | Human Liver | Human Spleen |
|---|---|---|---|---|---|
|
| TNF | LARP1 | RICTOR | RXRA | ATF4 |
| IL1A | MYC | LARP1 | NR1I2 | SBDS | |
| IL1B | MYCN | MLXIPL | ACOX1 | CREB1 | |
| NFkB (complex) | YAP1 | YAP1 | PPARA | CAB39L | |
| TGFB1 | MLXPL | MYC | APP | TFAP2D | |
|
|
|
|
|
| |
|
| IL1B | IL1B | IL1B | IL1B | |
| TGFB1 | TNF | TNF | IL6 | ||
| TNF | PPARA | IFNG | TNF | ||
| NFkB (complex)1.19E-37(Activated) | IL6 | IL-6 | NR3C1 |
Functional “core” analysis performed by IPA. p-values of overlap comparing values from meningococcal septic shock (n = 5) patients with controls (n = 2) (filtering criteria: FC ≥| ± 2|, p < 0.05).
Functional “core” analysis performed by IPA. p-values of overlap comparing values from porcinis (n = 8) infused exponentially increasing numbers of N. meningitidis (reference strain H44/76) vs. controls (n = 3) (filtering criteria: FC ≥| ± 2|, p < 0.05).
Figure 1Predicted biofunctions (A), canonical pathways (B), and upstream regulators (C) in FFPE tissue samples from patients with meningococcal septic shock and in organs from porcinis infused with exponentially increasing numbers of N. meningitidis (reference strain H44/76) vs. controls. ≪Comparison analysis≫ of biofunctions (A), canonical pathways (B), and upstream regulators (C), significantly enriched in FFPE tissue samples from lungs, heart, kidneys, liver, and spleen from meningococcal septic shock patients vs. control patients (acute non-infectious death) and in FF tissue samples from lungs, kidneys, liver and spleen from porcinis infused with exponentially increasing numbers of N. meningitidis (reference strain H44/76) vs. controls was performed. The figure shows the most upregulated biofunctions (A), canonical pathways (B), and upstream regulators (C) ranked according to expression levels in FFPE tissues from lungs. The Z-score indicates predicted activation state of the biofunctions, canonical pathways, and upstream regulators. Z-score values >| ± 2| are displayed. Dots display insignificant threshold Z-score values <± 2|. Blue color or lighter shades of blue indicate a negative Z-score and downregulation of a biofunction, canonical pathways, and upstream regulators. Orange or lighter shades of orange indicate a positive Z-score and upregulation of a biofunction, canonical pathways, and upstream regulators. Note that only the top pathways are shown.
Predicted biofunctions based on Z-score values in FFPE tissue samples from patients with meningococcal septic shock and in organs from porcinis infused with exponentially increasing numbers of N. meningitidis (reference strain H44/76) vs. controls.
| Z-score | Z-score | Z-score | Z-score | Z-score | Z-score | Z-score | Z-score | Z-score | |
|---|---|---|---|---|---|---|---|---|---|
| Diseases and Bio Functions | Lungs Human | Heart Human | Kidneys Human | Liver Human | Spleen Human | Lungs Porcine | Kidneys Porcine | Liver Porcine | Spleen Porcine |
| Migration of cells | 4.0 | 4.9 | 3.0 | 1.2 | N/A | 4.9 | 6.0 | 5.3 | 4.8 |
| Organismal death | −3.7 | −5.4 | −6.5 | N/A | N/A | −4.8 | −6.0 | −3.0 | −4.8 |
| Cell movement | 4.0 | 5.1 | 3.2 | 1.4 | N/A | 4.6 | 6.0 | 5.1 | 4.5 |
| Cellular homeostasis | 3.1 | 3.9 | 2.7 | 1.6 | N/A | 3.9 | 4.1 | 5.0 | 3.6 |
| Inflammatory response | 4.2 | 4.0 | N/A | 1.0 | N/A | 4.4 | 5.2 | 4.1 | 4.3 |
| Chemotaxis | 3.7 | 3.9 | N/A | 1.0 | N/A | 5.1 | 5.4 | 4.3 | 3.4 |
| Cell viability | 2.6 | 4.3 | 3.3 | 1.0 | N/A | 4.3 | 4.6 | 3.0 | 3.6 |
| Activation of cells | 1.8 | 1.8 | 2.3 | 1.4 | N/A | 5.8 | 5.1 | 3.7 | 4.8 |
| Leukocyte migration | 3.1 | 3.4 | N/A | 1.2 | N/A | 4.3 | 5.4 | 5.2 | 3.9 |
| Cell survival | 3.0 | 4.6 | 3.1 | N/A | N/A | 4.2 | 4.6 | 2.8 | 3.4 |
| Invasion of cells | 3.1 | 3.8 | 2.7 | N/A | N/A | 4.0 | 4.2 | 3.7 | 4.1 |
| Homing of cells | 3.7 | 3.9 | N/A | N/A | N/A | 5.0 | 5.3 | 4.5 | 3.3 |
| Chemotaxis of myeloid cells | 3.9 | 3.4 | N/A | 0.7 | N/A | 4.0 | 5.3 | 4.7 | 3.2 |
| Activation of leukocytes | 2.2 | 3.1 | N/A | 1.5 | N/A | 5.3 | 5.0 | 3.6 | 4.5 |
| Activation of myeloid cells | 3.1 | 3.5 | N/A | 1.4 | N/A | 4.8 | 4.8 | 2.9 | 4.1 |
| Chemotaxis of phagocytes | 3.7 | 3.4 | N/A | 0.9 | N/A | 3.7 | 5.0 | 4.5 | 2.8 |
| Cell movement of myeloid cells | 3.1 | 3.2 | N/A | 1.3 | N/A | 3.4 | 4.6 | 4.8 | 3.5 |
| Recruitment of myeloid cells | 3.0 | 2.9 | N/A | 2.0 | N/A | 3.8 | 4.9 | 4.3 | 3.0 |
| Recruitment of phagocytes | 2.8 | 2.8 | N/A | 1.9 | N/A | 3.8 | 5.1 | 4.3 | 3.0 |
| Binding of tumor cell lines | 2.7 | 3.6 | N/A | 1.5 | N/A | 3.5 | 4.5 | 3.8 | 4.1 |
| Activation of phagocytes | 3.1 | 3.4 | N/A | 1.4 | N/A | 4.5 | 4.4 | 2.4 | 4.2 |
| Recruitment of leukocytes | 2.7 | 2.3 | N/A | 1.4 | N/A | 4.2 | 4.9 | 4.2 | 3.6 |
| Cell movement of leukocytes | 3.1 | 3.3 | N/A | 0.7 | N/A | 3.5 | 4.4 | 4.9 | 3.2 |
| Chemotaxis of leukocytes | 3.9 | 3.6 | N/A | N/A | N/A | 3.6 | 5.0 | 4.1 | 2.6 |
| Adhesion of immune cells | 2.8 | 3.3 | N/A | N/A | N/A | 4.0 | 5.2 | 4.0 | 3.4 |
| Cell movement of phagocytes | 2.9 | 2.8 | N/A | 0.7 | N/A | 3.3 | 4.5 | 4.9 | 3.3 |
| Chemotaxis of granulocytes | 3.2 | 3.3 | N/A | N/A | N/A | 3.9 | 4.8 | 4.1 | 2.9 |
| Cell movement of granulocytes | 2.5 | 3.6 | 1.0 | N/A | N/A | 3.4 | 4.9 | 3.9 | 2.9 |
| Activation of antigen presenting cells | 3.2 | 2.8 | N/A | 1.2 | N/A | 4.2 | 3.7 | 2.0 | 4.0 |
| Leukopoiesis | 1.6 | 2.7 | N/A | 0.0 | N/A | 3.6 | 4.5 | 4.6 | 4.2 |
| Morbidity or mortality | −3.6 | N/A | N/A | N/A | N/A | −4.6 | −5.5 | −2.8 | −4.6 |
| Activation of macrophages | 3.4 | 2.6 | N/A | 1.4 | N/A | 4.0 | 3.7 | 2.2 | 3.7 |
≪Comparison analysis≫ of biofunctions significantly enriched in FFPE tissue samples from lungs, heart, kidneys, liver, and spleen from meningococcal septic shock patients vs. control patients (acute non-infectious death) and in FF tissue samples from lungs, kidneys, liver, and spleen from porcinis infused with exponentially increasing numbers of N. meningitidis (reference strain H44/76) vs. controls were performed. The table shows the top most upregulated biofunctions ranked according to expression levels in FFPE tissues from lungs. The Z-score indicates predicted activation state of the biofunctions. Note that only the top biofunctions are shown. N/A = not applicable.
Predicted canonical pathways based on Z-score values in FFPE tissue samples from patients with meningococcal septic shock and in organs from porcinis infused with exponentially increasing numbers of N. meningitidis (reference strain H44/76) vs. controls.
| Z-score | Z-score | Z-score | Z-score | Z-score | Z-score | Z-score | Z-score | Z-score | |
|---|---|---|---|---|---|---|---|---|---|
| Canonical Pathways | Lungs Human | Heart Human | Kidneys Human | Liver Human | Spleen Human | Lungs Porcine | Kidneys Porcine | Liver Porcine | Spleen Porcine |
| IL-17 Signaling | 3.0 | 2.8 | N/A | N/A | N/A | 4.4 | 4.0 | 4.1 | 4.5 |
| HMGB1 Signaling | 2.2 | 2.2 | N/A | N/A | N/A | 4.2 | 4.2 | 4.2 | 3.8 |
| Dendritic Cell Maturation | 2.0 | 2.0 | N/A | N/A | N/A | 4.4 | 4.0 | 4.4 | 3.9 |
| Cardiac Hypertrophy Signaling (Enhanced) | 2.2 | 3.0 | N/A | N/A | N/A | 4.4 | 4.1 | 3.3 | 3.0 |
| Acute Phase Response Signaling | 3.0 | 2.4 | 2.6 | N/A | N/A | 2.7 | 3.9 | 1.1 | 3.0 |
| TREM1 Signaling | 2.4 | 2.6 | N/A | N/A | N/A | 3.4 | 3.3 | 3.4 | 2.8 |
| LXR/RXR Activation | −1.3 | −1.0 | N/A | −1.0 | N/A | −3.3 | −2.7 | −5.0 | −2.1 |
| PPAR Signaling | N/A | −2.2 | −2.0 | N/A | N/A | −2.8 | −3.2 | −3.2 | −2.7 |
| Differential Regulation of Cytokine Production in Macrophages and T Helper Cells by IL-17A and IL-17F | 2.6 | 2.0 | N/A | N/A | N/A | 3.0 | 2.6 | 2.8 | 2.8 |
| IL-6 Signaling | 2.4 | 2.2 | N/A | N/A | N/A | 2.8 | 3.4 | 2.2 | 2.8 |
| p38 MAPK Signaling | 2.2 | N/A | N/A | N/A | N/A | 3.0 | 3.5 | 2.1 | 3.3 |
| Senescence Pathway | 1.3 | 1.6 | 1.3 | N/A | N/A | 2.5 | 2.7 | 1.7 | 2.5 |
| Th17 Activation Pathway | 2.2 | −0.4 | N/A | N/A | N/A | 3.2 | 2.0 | 3.0 | 2.3 |
| Tec Kinase Signaling | N/A | N/A | N/A | N/A | N/A | 3.3 | 3.2 | 3.5 | 2.5 |
| PPARα/RXRα Activation | −1.0 | −2.0 | N/A | N/A | N/A | −2.1 | −2.2 | −2.3 | −2.5 |
| HIF1α Signaling | 1.3 | 0.7 | 1.1 | N/A | N/A | 2.7 | 2.1 | 2.0 | 1.9 |
| Regulation of the Epithelial Mesenchymal Transition by Growth Factors Pathway | N/A | N/A | N/A | N/A | N/A | 3.0 | 3.0 | 2.9 | 3.1 |
| Crosstalk between Dendritic Cells and Natural Killer Cells | N/A | N/A | N/A | N/A | N/A | 3.1 | 2.7 | 3.2 | 2.9 |
| Toll-like Receptor Signaling | 1.9 | N/A | N/A | N/A | N/A | 2.6 | 2.8 | 2.3 | 2.1 |
| Natural Killer Cell Signaling | N/A | N/A | N/A | N/A | N/A | 2.6 | 2.2 | 3.9 | 2.9 |
| IL-15 Signaling | N/A | N/A | N/A | N/A | N/A | 3.0 | 2.6 | 3.2 | 2.5 |
| Cholecystokinin/Gastrin-mediated Signaling | N/A | N/A | N/A | N/A | N/A | 2.8 | 2.8 | 2.8 | 2.6 |
| Ferroptosis Signaling Pathway | 1.6 | 2.0 | 1.3 | N/A | N/A | 1.1 | 1.9 | 1.7 | 1.3 |
| Production of Nitric Oxide and Reactive Oxygen Species in Macrophages | N/A | N/A | N/A | N/A | N/A | 3.7 | 3.5 | 0.4 | 3.2 |
| Oncostatin M Signaling | N/A | N/A | N/A | N/A | N/A | 2.6 | 2.4 | 2.8 | 2.8 |
| Role of Pattern Recognition Receptors in Recognition of Bacteria and Viruses | N/A | N/A | N/A | N/A | N/A | 2.5 | 3.2 | 3.2 | 1.7 |
| Thrombopoietin Signaling | N/A | N/A | N/A | N/A | N/A | 2.6 | 2.4 | 2.6 | 2.3 |
| Myc Mediated Apoptosis Signaling | N/A | N/A | N/A | N/A | N/A | 2.4 | 2.3 | 2.4 | 2.6 |
| IL-3 Signaling | N/A | N/A | N/A | N/A | N/A | 2.4 | 2.2 | 2.6 | 2.3 |
| NF-κB Signaling | −1.3 | N/A | N/A | N/A | N/A | 1.9 | 2.5 | 2.8 | 1.0 |
| IL-8 Signaling | 2.0 | N/A | N/A | N/A | N/A | 2.5 | 1.9 | 2.7 | 0.3 |
| TNFR1 Signaling | N/A | N/A | N/A | N/A | N/A | 2.2 | 2.4 | 2.0 | 2.4 |
| PDGF Signaling | N/A | N/A | N/A | N/A | N/A | 2.4 | 2.2 | 2.4 | 1.9 |
| Integrin Signaling | N/A | N/A | N/A | N/A | N/A | 2.0 | 2.6 | 3.2 | 1.1 |
| Retinoic acid Mediated Apoptosis Signaling | N/A | N/A | N/A | N/A | N/A | 2.0 | 2.2 | 2.2 | 2.4 |
| EIF2 Signaling | N/A | 3.8 | 2.8 | N/A | N/A | N/A | N/A | 2.2 | N/A |
≪Comparison analysis≫ of canonical pathways significantly enriched in FFPE tissue samples from lungs, heart, kidneys, liver, and spleen from meningococcal septic shock patients vs. controls patients (acute non-infectious death) and in FF tissue samples from lungs, kidneys, liver, and spleen from porcinis infused with exponentially increasing numbers of N. meningitidis (reference strain H44/76) vs. controls were performed. The table shows the top most upregulated canonical pathways ranked according to expression levels in FFPE tissues from lungs. The Z-score indicates predicted activation state of the canonical pathways. Note that only the top canonical pathways are shown. N/A = not applicable.
Figure 2Predicted gene signaling pathways from the top upregulated canonical pathways in FFPE tissue samples from patients with meningococcal septic shock and in organs from porcinis infused with exponentially increasing numbers of N. meningitidis (reference strain H44/76) vs. controls. The Z-score indicates predicted activation state of canonical pathways in the tissue samples from meningococcal septic shock patients vs. controls and in organs from porcinis infused with exponentially increasing numbers of N. meningitidis (reference strain H44/76) vs. controls. Orange or lighter shades of orange indicate a positive Z-score and upregulation of the pathway. The transcripts in the gene signaling pathway are expressed as fold change (FC) values. Red or lighter shades of red indicate positive FC-values and upregulation of transcripts; green color or lighter shades of green indicate negative FC-values and downregulation of transcripts. The color gray indicates that a predicted activation state of a gene/transcript in the canonical pathway signaling network is not affected, the gene/transcript was in the dataset but did not pass the analysis cutoffs. White color indicates that gene/transcript are not present in the dataset.
Figure 3Predicted gene signaling pathways from the top downregulated canonical pathways in FFPE tissue samples from patients with meningococcal septic shock and in organs from porcinis infused with exponentially increasing numbers of N. meningitidis (reference strain H44/76) vs. controls.The Z-score indicates predicted activation state of canonical pathways in the tissue samples from meningococcal septic shock patients vs. controls and in organs from porcinis infused with exponentially increasing numbers of N. meningitidis (reference strain H44/76) vs. controls. Orange or lighter shades of orange indicate a positive Z-score and upregulation of the pathway. Blue color or lighter shades of blue indicate a negative Z-score and downregulation of the pathway. The transcripts in the gene signaling pathway are expressed as fold change (FC) values. Red or lighter shades of red indicate positive FC-values and upregulation of transcripts; green color or lighter shades of green indicate negative FC-values and downregulation of transcripts. The color gray indicates that a predicted activation state of a gene/transcript in the canonical pathway signaling network is not affected, the gene/transcript was in the dataset but did not pass the analysis cutoffs. White color indicates that gene/transcript are not present in the dataset.
Predicted upstream regulators based on Z-score values in FFPE tissue samples from patients with meningococcal septic shock and in organs from porcinis infused with exponentially increasing numbers of N. meningitidis (reference strain H44/76) vs. controls.
| Z-score | Z-score | Z-score | Z-score | Z-score | Z-score | Z-score | Z-score | Z-score | |
|---|---|---|---|---|---|---|---|---|---|
| Upstream Regulators | Lungs Human | Heart Human | Kidneys Human | Liver Human | Spleen Human | Lungs Porcine | Kidneys Porcine | Liver Porcine | Spleen Porcine |
| IL1B | 5.2 | 5.8 | 3.3 | 3.6 | N/A | 8.1 | 7.6 | 6.0 | 8.0 |
| TNF | 5.5 | 5.8 | 3.6 | 2.9 | N/A | 7.3 | 8.0 | 6.4 | 7.7 |
| IFNG | 3.6 | 4.6 | 3.7 | 2.2 | N/A | 6.4 | 7.5 | 6.4 | 6.2 |
| NFkB (complex) | 4.6 | 4.6 | 2.6 | 2.0 | N/A | 6.8 | 6.4 | 6.5 | 6.8 |
| IL1A | 4.6 | 4.5 | 3.5 | 2.8 | N/A | 5.3 | 5.7 | 5.0 | 5.8 |
| IL1 | 4.3 | 4.1 | 2.9 | 2.0 | N/A | 5.0 | 5.6 | 5.2 | 5.4 |
| OSM | 3.6 | 4.3 | 3.4 | 2.8 | N/A | 5.1 | 5.7 | 4.0 | 5.1 |
| TLR3 | 3.9 | 4.0 | 2.8 | 2.6 | N/A | 5.1 | 4.7 | 5.1 | 5.7 |
| TLR4 | 3.5 | 3.5 | 1.7 | 2.2 | N/A | 5.8 | 5.8 | 6.0 | 5.3 |
| IL6 | 3.8 | 4.5 | 3.9 | 2.4 | N/A | 4.6 | 5.4 | 3.4 | 5.7 |
| RELA | 4.0 | 4.0 | 1.3 | 2.4 | N/A | 5.9 | 5.3 | 4.8 | 5.1 |
| P38 MAPK | 3.2 | 3.9 | 2.4 | 2.0 | N/A | 5.9 | 5.3 | 4.5 | 5.5 |
| F2 | 3.9 | 4.2 | 2.4 | 2.0 | N/A | 5.2 | 5.3 | 4.4 | 5.0 |
| CSF2 | 3.3 | 4.0 | 2.4 | 2.4 | N/A | 5.8 | 5.0 | 4.6 | 4.5 |
| TLR9 | 2.9 | 3.4 | 2.2 | 1.7 | N/A | 5.4 | 5.2 | 5.3 | 5.6 |
| Interferon alpha | 2.4 | 2.9 | 1.3 | 2.0 | N/A | 5.5 | 5.9 | 6.1 | 5.8 |
| AGT | 2.6 | 3.5 | 2.7 | 0.6 | N/A | 5.3 | 6.0 | 5.0 | 4.9 |
| MYD88 | 3.4 | 3.9 | 2.2 | N/A | N/A | 5.5 | 5.1 | 5.3 | 5.0 |
| EGF | 3.6 | 4.1 | 2.0 | 1.9 | N/A | 4.9 | 5.1 | 3.7 | 5.0 |
| IL2 | 3.4 | 2.6 | 1.4 | N/A | N/A | 5.7 | 5.6 | 5.5 | 5.6 |
| PDGF BB | 2.7 | 4.1 | 2.7 | 2.4 | N/A | 4.4 | 4.7 | 3.1 | 5.0 |
| APP | 3.2 | 2.6 | 1.2 | 1.2 | N/A | 5.6 | 5.4 | 4.3 | 5.5 |
| TLR7 | 3.6 | 3.8 | N/A | 2.0 | N/A | 4.7 | 4.8 | 5.1 | 4.7 |
| IKBKB | 3.2 | 3.6 | 1.8 | 2.4 | N/A | 5.0 | 4.5 | 4.1 | 3.8 |
| CD3 | 3.7 | 3.7 | 2.4 | 0.8 | N/A | 4.5 | 4.5 | 4.3 | 4.2 |
| CD40LG | 2.6 | 2.9 | 2.2 | 2.2 | N/A | 4.5 | 4.6 | 4.2 | 4.6 |
| STAT1 | 2.4 | 3.1 | 3.0 | N/A | N/A | 4.1 | 5.2 | 5.3 | 4.4 |
| Jnk | 3.1 | 3.2 | 2.0 | N/A | N/A | 5.1 | 4.7 | 4.4 | 4.9 |
| IL33 | 3.5 | 3.5 | 1.3 | 2.2 | N/A | 4.7 | 3.6 | 3.7 | 4.5 |
| TICAM1 | 2.8 | 3.1 | N/A | N/A | N/A | 5.4 | 4.9 | 5.2 | 5.4 |
| LDL | 2.9 | 3.2 | 2.4 | 0.8 | N/A | 4.9 | 4.6 | 4.5 | 3.5 |
| Ige | 3.4 | 3.5 | N/A | N/A | N/A | 4.8 | 4.6 | 5.3 | 5.0 |
| IL17A | 3.6 | 3.9 | N/A | 0.9 | N/A | 4.7 | 5.0 | 4.3 | 3.9 |
| IFNA2 | 3.0 | 3.6 | 1.9 | N/A | N/A | 3.9 | 4.5 | 4.7 | 4.8 |
| NFKB1 | 2.9 | 2.6 | 1.2 | 2.0 | N/A | 4.9 | 4.4 | 3.8 | 4.4 |
≪Comparison analysis≫ of upstream regulators significantly enriched in FFPE tissue samples from lungs, heart, kidneys, liver, and spleen from meningococcal septic shock patients vs. controls patients (acute non-infectious death) and in FF tissue samples from lungs, kidneys, liver, and spleen from porcinis infused with exponentially increasing numbers of N. meningitidis (reference strain H44/76) vs. controls were performed. The table shows the top most upregulated upstream regulators ranked according to expression levels in FFPE tissues from lungs. The Z-score indicates predicted activation state of the upstream regulators. Note that only the top upstream regulators are shown. N/A = not applicable.
Figure 4Predicted gene signaling pathways from the top upregulated upstream regulators in FFPE tissue samples from patients with meningococcal septic shock and in organs from porcinis infused with exponentially increasing numbers of N. meningitidis (reference strain H44/76) vs. controls. The Z-score indicates predicted activation state of genes in the upstream regulator signaling network. Orange or lighter shades of orange indicate a positive Z-score and upregulation of the upstream regulator. The transcripts in the signaling network are expressed as Fold Change (FC) values. Red or lighter shades of red indicates positive FC-values and upregulation of transcripts; green color or lighter shades of green indicate negative FC-values and downregulation of transcripts. The color gray indicates that a predicted activation state of a gene/transcript in the upstream regulator pathway signaling network is not affected (the gene/transcript was in the dataset but did not pass the analysis cutoffs). White color indicates that gene/transcript are not present in the dataset.
Figure 5Predicted gene signaling pathways from the top downregulated upstream regulators in FFPE tissue samples from patients with meningococcal septic shock and in organs from porcinis infused with exponentially increasing numbers of N. meningitidis (reference strain H44/76) vs. controls. The Z-score indicates predicted activation state of genes in the upstream regulator signaling network. Orange or lighter shades of orange indicate a positive Z-score and upregulation of the upstream regulator signaling network. Blue color or lighter shades of blue indicate a negative Z-score and downregulation of the upstream regulator. The transcripts in the signaling network are expressed as fold change (FC) values. Red or lighter shades of red indicate positive FC-values and upregulation of transcripts; green color or lighter shades of green indicate negative FC-values and downregulation of transcripts. The color gray indicates that a predicted activation state of a gene/transcript in the upstream regulator pathway signaling network is not affected (the gene/transcript was in the dataset but did not pass the analysis cutoffs). White color indicates that gene/transcript are not present in the dataset.
Figure 6Cytokine concentration in fresh frozen tissue samples from patients with meningococcal septic shock (n = 3) and in fresh frozen tissue samples from the experimental porcine model (n = 8). The concentration unit is ng/g for the organ samples.
| CCL2 | C-C motif chemokine ligand 2 (alias MCP1) |
| CEBPA | CCAAT enhancer binding protein alpha |
|
| capsule transport A |
| CXCL1 | chemokine (C-X-C motif) ligand 1 (alias GRO1) |
| CXCL2 | chemokine (C-X-C motif) ligand 2 (alias MIP-2α) |
| CXCL8 | chemokine (C-X-C motif) ligand 8 (alias IL-8) |
| DIC | disseminated intravascular coagulation |
| EDN1 | endothelin 1 |
| EIF2 | eukaryotic Initiation factor 2 |
| FC | fold changes |
| FDR | false discovery rate |
| FF | fresh frozen |
| FFPE | formalin-fixed, paraffin-embedded |
| FGG | fibrinogen gamma gene |
| G-CSF | granulocyte-colony stimulating factor (alias CFR 3) |
| GEO | Gene Expression Omnibus |
| HMBG1 | High mobility group box 1 protein, 1 |
| HSP90B1 | Heat shock protein 90kDa beta member 1 |
| ICAM | intercellular adhesion molecules (alias CD 54) |
| IFNG | Interferon gamma |
| IL | interleukin |
| IL1RN | interleukin-1 receptor antagonist (IL-1RA) |
| IL1RL1 | Interleukin 1 receptor-like 1 (ST2) |
| IPA | ingenuity pathway analysis |
| ITGA5 | integrin alpha-5 |
| LPS | lipopolysaccharides |
| LXR | liver X receptor |
| MCP-1 | monocyte chemoattractant protein-1 (alias CCL2) |
| MIAME | minimum information about a microarray experiment |
| MSS | meningococcal septic shock |
| NF-κB | nuclear factor kappa-light-chain-enhancer of activated B cells |
| NFKB1A | NF-kappa-B inhibitor alpha |
| NmDNA |
|
| OSM | oncostatin M |
| PAI-1 | plasminogen activator inhibitor-1 (alias SEPINE 1) |
| PPAR | peroxisome proliferator-activated receptors |
| RXR | retinoid X receptor |
| S100A9 | calcium binding protein A9 (calgranulin B) |
| RT | room temperature |
| SELE | E-selectin |
| TF | tissue factor |
| TIMP | tissue inhibitor of metalloproteinase 1 |
| TLRs | toll-like receptor family |
| TNF | tumor necrosis factor |
| TNFAIP3 | tumor necrosis factor, alpha-induced protein 3 |
| TREM1 | triggering receptor expressed on myeloid cells 1 |
| VCAM-1 | vascular cell adhesion molecule 1 |
| VIP | vasoactive intestinal peptide. |